HEPATOCELLULAR CARCINOMA RECURRENT
Clinical trials for HEPATOCELLULAR CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients battling returned liver cancer
Disease control Recruiting nowThis study is testing whether a promising two-drug cancer treatment is safe for people whose liver cancer returned after a transplant. It will enroll 50 liver transplant patients to see if the treatment can control their advanced cancer without causing their body to reject the tr…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Last-Hope device trial for tough liver cancer cases
Disease control Recruiting nowThis study is testing a device called the TheraBionic P1 for people with advanced liver cancer (hepatocellular carcinoma) who have no standard treatment options left. The main goal is to see if using this device can help patients live longer. Researchers will also check how safe …
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC